Position in CYTK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,896
+$1,249 QoQ
Shares Held
34
+36.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#438
of 477 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hughes Financial Services, LLC holds $150,199 across 98 Biotechnology names. CYTK ranks #11 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RIGL |
Rigel Pharmaceuticals Inc
|
1,601 | $62,631 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19 | $9,437 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
31 | $9,331 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12 | $7,482 | |
| 5 | MRNA |
Moderna, Inc.
|
72 | $5,042 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
15 | $4,741 | |
| 7 | EXEL |
Exelixis, Inc.
|
87 | $4,733 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
7 | $3,758 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,896 | 34 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,647 | 25 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,779 | 28 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,758 | 32 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,057 | 32 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $442 | 11 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||